Finder makes money from featured partners, but editorial opinions are our own.

How to buy Avita Medical (AVH) shares in Australia

Learn how to easily invest in Avita Medical shares.

Avita Medical is a medical devices business based in Australia. Avita Medical shares (AVH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Avita Medical has a trailing 12-month revenue of around $45.4 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Avita Medical

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Avita Medical. Find the share by name or ticker symbol: AVH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avita Medical reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check on your investment. Congratulations, you own a part of Avita Medical. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

Avita Medical stock price (ASX:AVH)

Use our graph to track the performance of AVH stocks over time.

Avita Medical shares at a glance

Information last updated 2023-11-27.
52-week range$1.88 - $6.27
50-day moving average $3.6434
200-day moving average $4.2862
Target price$6.02
PE ratio 0
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.41

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 6 of 6
Name Product Standard brokerage fee Inactivity fee Asset class
Finder AwardExclusive
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
CFD service. Capital at risk.
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
ASX shares, Global shares, US shares, UK shares, ETFs
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian and international shares, plus get access to 24-hour customer support.
Moomoo Share Trading
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get an additional 30 days on top of the regular brokerage-free period for new accounts (see link for details). T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 18 million investors.
CMC Invest
Finder Award
CMC Invest
ASX shares, Global shares, Options trading, US shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 35,000 products, including shares, crypto, ETFs and managed funds, with access to 15 major global and Australian stock exchanges. Plus, buy Aussie shares for $0 brokerage up to $1,000. (Limited to one buy order per stock per trading day).
ASX shares, Options trading, US shares, ETFs
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Tiger Brokers
Tiger Brokers
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 15 commission-free trades on US or ASX equities for the first 180 days and US$50 fractional shares when you deposit at least US$500. Plus, all new customers get 1 free trade per month for the first 12 months (T&Cs apply).
Get one brokerage-free trade per month for the first 12 months for US or ASX markets. T&Cs apply.

Is it a good time to buy Avita Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Avita Medical price performance over time

Historical closes compared with the last close of A$3.29

1 week (2023-11-23) -0.90%
1 month (2023-11-01) 10.77%
3 months (2023-09-01) -33.27%
6 months (2023-06-01) -8.61%
1 year (2022-12-01) 61.27%
2 years (2021-12-01) -13.65%
3 years (2020-12-01) -44.24%
5 years (2018-11-30) -89.97%

Avita Medical financials

Revenue TTM $45.4 million
Gross profit TTM $28.4 million
Return on assets TTM -25.01%
Return on equity TTM -44.61%
Profit margin -74.16%
Book value 2.465
Market capitalisation $416.5 million

TTM: trailing 12 months

Avita Medical share dividends

We're not expecting Avita Medical to pay a dividend over the next 12 months.

Have Avita Medical's shares ever split?

Avita Medical's shares were split on a 5:100 basis on 24 June 2020. So if you had owned 100 shares the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Avita Medical shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Avita Medical shares which in turn could have impacted Avita Medical's share price.

Avita Medical share price volatility

Over the last 12 months, Avita Medical's shares have ranged in value from as little as $1.88 up to $6.27. A popular way to gauge a stock's volatility is its "beta".

AVH.AU volatility(beta: 1.53)Avg. volatility(beta: 1.00)LowHigh

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Avita Medical's is 1.534. This would suggest that Avita Medical's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).

Avita Medical overview

AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and 6. Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site